Cytek Biosciences, Inc. (CTKB)
NASDAQ · Healthcare
Cytek Biosciences, Inc. Total Liabilities 2020–2025
Cytek Biosciences, Inc. annual/quarterly total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Cytek Biosciences, Inc. total liabilities for the quarter ending December 31, 2025 were 119.8M, a 15.46% increase year-over-year.
- Cytek Biosciences, Inc. total liabilities for 2025 were 119.8M, a 15.46% increase from 2024.
- Cytek Biosciences, Inc. total liabilities for 2024 were 103.8M, a 2.34% increase from 2023.
- Cytek Biosciences, Inc. total liabilities for 2023 were 101.4M, a 7.95% increase from 2022.
- Cytek Biosciences, Inc. total liabilities for 2022 were 93.9M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Cytek Biosciences, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $120 |
| 2024 | $104 |
| 2023 | $101 |
| 2022 | $94 |
| 2021 | $58 |
| 2020 | $42 |
| Cytek Biosciences, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $120 |
| 2024-12-31 | $104 |
| 2023-12-31 | $101 |
| 2022-12-31 | $94 |
| 2021-12-31 | $58 |
| 2020-12-31 | $42 |
Cytek Biosciences, Inc. Total Liabilities — FAQ
Cytek Biosciences, Inc. (CTKB) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CTKB's total liabilities history?
The chart and table above show Cytek Biosciences, Inc.'s total liabilities by year and by quarter, including the growth rate.